| Number | Sample # | Block Code | X Coord | Y Coord | Tumor Type | Sex | Age | Limitations | Other Information |
|---|---|---|---|---|---|---|---|---|---|
| 501 | 1 | marker core | 0 | 0 | Liver | ||||
| 451 | 1 | normal tissue | 1 | 1 | adrenal | XX-00-21A | |||
| 456 | 6 | normal tissue | 1 | 2 | breast | XX-00-35 | |||
| 461 | 11 | normal tissue | 1 | 3 | cerebellum | XX-00-17-1A | |||
| 466 | 16 | normal tissue | 1 | 4 | esophagus | XX-00-24E | |||
| 471 | 21 | normal tissue | 1 | 5 | liver | L | |||
| 476 | 26 | normal tissue | 1 | 7 | lymph node | ||||
| 481 | 31 | normal tissue | 1 | 8 | ovary | ||||
| 486 | 36 | normal tissue | 1 | 9 | prostate | ||||
| 491 | 41 | normal tissue | 1 | 10 | small bowel | ||||
| 496 | 46 | normal tissue | 1 | 11 | testis | ||||
| 26 | 1 | YY-00-0054 | 1 | 14 | Breast Adenocarcinoma | F | 67 | limited | ductal |
| 31 | 6 | YY-00-0060 | 1 | 15 | Breast Adenocarcinoma | F | 37 | limited | poorly differentiated |
| 36 | 11 | YY-00-0066 | 1 | 16 | Breast Adenocarcinoma | F | 62 | poorly differentiated | |
| 41 | 16 | YY-00-0178 | 1 | 17 | Breast Adenocarcinoma | F | 34 | ductal | |
| 46 | 21 | YY-00-0183 | 1 | 18 | Breast Adenocarcinoma | F | 70 | ductal | |
| 51 | 26 | YY-00-0191 | 1 | 20 | Breast Adenocarcinoma | F | 43 | limited | ductal |
| 56 | 31 | YY-00-0199 | 1 | 21 | Breast Adenocarcinoma | F | 62 | ductal | |
| 61 | 36 | YY-00-0210 | 1 | 22 | Breast Adenocarcinoma | F | 59 | ductal | |
| 66 | 41 | YY-00-0215 | 1 | 23 | Breast Adenocarcinoma | F | 49 | limited | ductal, IPOX ER, PR positive |
| 71 | 46 | YY-00-0332 | 1 | 24 | Breast Adenocarcinoma | F | U | poorly differentiated | |
| 76 | 51 | YY-00-0343 | 1 | 26 | Breast Adenocarcinoma | F | U | ductal | |
| 81 | 56 | YY-00-0352 | 1 | 27 | Breast Adenocarcinoma | F | U | ductal | |
| 86 | 61 | YY-00-0359 | 1 | 28 | Breast Adenocarcinoma | F | 67 | ductal | |
| 91 | 66 | YY-01-0004 | 1 | 29 | Breast Adenocarcinoma | F | 85 | limited | ductal |
| 96 | 71 | YY-01-0009 | 1 | 30 | Breast Adenocarcinoma | F | 56 | ductal, met to LN | |
| 452 | 2 | normal tissue | 2 | 1 | adrenal | ||||
| 457 | 7 | normal tissue | 2 | 2 | breast | ||||
| 462 | 12 | normal tissue | 2 | 3 | cerebrum, gray matter | XX-00-17-2A | |||
| 467 | 17 | normal tissue | 2 | 4 | esophagus | ||||
| 472 | 22 | normal tissue | 2 | 5 | liver | ||||
| 477 | 27 | normal tissue | 2 | 7 | lymph node | ||||
| 482 | 32 | normal tissue | 2 | 8 | ovary | ||||
| 487 | 37 | normal tissue | 2 | 9 | prostate | ||||
| 492 | 42 | normal tissue | 2 | 10 | small bowel | ||||
| 497 | 47 | normal tissue | 2 | 11 | thyroid | ||||
| 27 | 2 | YY-00-0055 | 2 | 14 | Breast Adenocarcinoma | F | 79 | ductal | |
| 32 | 7 | YY-00-0062 | 2 | 15 | Breast Adenocarcinoma | F | 43 | limited | ductal, with DCIS present |
| 37 | 12 | YY-00-0069 | 2 | 16 | Breast Adenocarcinoma | F | 76 | ductal | |
| 42 | 17 | YY-00-0179 | 2 | 17 | Breast Adenocarcinoma | F | 37 | DCIS only | |
| 47 | 22 | YY-00-0184 | 2 | 18 | Breast Adenocarcinoma | M | 71 | limited | ductal |
| 52 | 27 | YY-00-0192 | 2 | 20 | Breast Adenocarcinoma | F | 53 | ductal | |
| 57 | 32 | YY-00-0203 | 2 | 21 | Breast Adenocarcinoma | F | 74 | limited | ductal |
| 62 | 37 | YY-00-0211 | 2 | 22 | Breast Adenocarcinoma | F | 56 | ductal | |
| 67 | 42 | YY-00-0216 | 2 | 23 | Breast Adenocarcinoma | F | 61 | limited | ductal IPOX ER positive, PR negative, c-erb-B2 3+ |
| 72 | 47 | YY-00-0333 | 2 | 24 | Breast Adenocarcinoma | F | 36 | limited | ductal |
| 77 | 52 | YY-00-0346 | 2 | 26 | Breast Adenocarcinoma | F | U | ductal | |
| 82 | 57 | YY-00-0353 | 2 | 27 | Breast Adenocarcinoma | F | U | ductal | |
| 87 | 62 | YY-00-0361 | 2 | 28 | Breast Adenocarcinoma | F | U | lobular | |
| 92 | 67 | YY-01-0005 | 2 | 29 | Breast Adenocarcinoma | F | 36 | ductal, met to LN, ER and PR+, c-erb-B2 3+ | |
| 97 | 72 | YY-01-0011 | 2 | 30 | Breast Adenocarcinoma | F | 74 | ductal, ER and PR +, cerb-B2 2+ | |
| 453 | 3 | normal tissue | 3 | 1 | bladder | XX-00-19A | |||
| 458 | 8 | normal tissue | 3 | 2 | breast | ||||
| 463 | 13 | normal tissue | 3 | 3 | cerebrum, white matter | XX-00-17-3A | |||
| 468 | 18 | normal tissue | 3 | 4 | heart | XX-00-25A | |||
| 473 | 23 | normal tissue | 3 | 5 | lung | XX-00-7 | |||
| 478 | 28 | normal tissue | 3 | 7 | mesothelium | ||||
| 483 | 33 | normal tissue | 3 | 8 | pancreas | ||||
| 488 | 38 | normal tissue | 3 | 9 | salivary gland | ||||
| 493 | 43 | normal tissue | 3 | 10 | spleen | ||||
| 498 | 48 | normal tissue | 3 | 11 | tongue | ||||
| 28 | 3 | YY-00-0056 | 3 | 14 | Breast Adenocarcinoma | F | 49 | lobular with signet ring features | |
| 33 | 8 | YY-00-0063 | 3 | 15 | Breast Adenocarcinoma | F | 48 | ductal | |
| 38 | 13 | YY-00-0175 | 3 | 16 | Breast Adenocarcinoma | F | 40 | ductal | |
| 43 | 18 | YY-00-0180 | 3 | 17 | Breast Adenocarcinoma | F | 27 | ductal | |
| 48 | 23 | YY-00-0186 | 3 | 18 | Breast Adenocarcinoma | F | 45 | ductal | |
| 53 | 28 | YY-00-0193 | 3 | 20 | Breast Adenocarcinoma | F | 68 | ductal | |
| 58 | 33 | YY-00-0205 | 3 | 21 | Breast Adenocarcinoma | F | 67 | limited | ductal |
| 63 | 38 | YY-00-0212 | 3 | 22 | Breast Adenocarcinoma | F | 71 | ductal | |
| 68 | 43 | YY-00-0218 | 3 | 23 | Breast Adenocarcinoma | F | 57 | ductal IPOX positive for ER, PR (focal) | |
| 73 | 48 | YY-00-0337 | 3 | 24 | Breast Adenocarcinoma | F | 75 | ductal IPOX positive ER (15%), negative PR, c-erb-B2 | |
| 78 | 53 | YY-00-0348 | 3 | 26 | Breast Adenocarcinoma | F | U | ductal | |
| 83 | 58 | YY-00-0354 | 3 | 27 | Breast Adenocarcinoma | F | U | lobular with signet rings | |
| 88 | 63 | YY-00-0463 | 3 | 28 | Breast Adenocarcinoma | F | 56 | ductal | |
| 93 | 68 | YY-01-0006 | 3 | 29 | Breast Adenocarcinoma | F | 51 | ductal, ER and PR negative, c-erb-B2 3+ | |
| 98 | 73 | YY-01-0012 | 3 | 30 | Breast Adenocarcinoma | F | 48 | limited | with in situ, ER and PR+, c-erbB-2 3+ |
| 454 | 4 | normal tissue | 4 | 1 | bladder | ||||
| 459 | 9 | normal tissue | 4 | 2 | breast | ||||
| 464 | 14 | normal tissue | 4 | 3 | colon | XX-00-10B | |||
| 469 | 19 | normal tissue | 4 | 4 | kidney, cortex | XX-00-9A | |||
| 474 | 24 | normal tissue | 4 | 5 | lung | ||||
| 479 | 29 | normal tissue | 4 | 7 | mesothelium | ||||
| 484 | 34 | normal tissue | 4 | 8 | peripheral nerve | ||||
| 489 | 39 | normal tissue | 4 | 9 | skin | ||||
| 494 | 44 | normal tissue | 4 | 10 | spleen | ||||
| 499 | 49 | normal tissue | 4 | 11 | uterus, endometrium | ||||
| 29 | 4 | YY-00-0057 | 4 | 14 | Breast Adenocarcinoma | F | 70 | limited | ductal |
| 34 | 9 | YY-00-0064 | 4 | 15 | Breast Adenocarcinoma | F | 60 | ductal | |
| 39 | 14 | YY-00-0176 | 4 | 16 | Breast Adenocarcinoma | F | 74 | limited | ductal |
| 44 | 19 | YY-00-0181 | 4 | 17 | Breast Adenocarcinoma | F | 35 | ductal | |
| 49 | 24 | YY-00-0188 | 4 | 18 | Breast Adenocarcinoma | F | 69 | ductal, IPOX ER, PR negative | |
| 54 | 29 | YY-00-0196 | 4 | 20 | Breast Adenocarcinoma | F | 48 | ductal | |
| 59 | 34 | YY-00-0208 | 4 | 21 | Breast Adenocarcinoma | F | 53 | limited | lobular |
| 64 | 39 | YY-00-0213 | 4 | 22 | Breast Adenocarcinoma | F | 57 | limited | ductal |
| 69 | 44 | YY-00-0219 | 4 | 23 | Breast Adenocarcinoma | F | 70 | lobular | |
| 74 | 49 | YY-00-0339 | 4 | 24 | Breast Adenocarcinoma | F | 72 | limited | ductal |
| 79 | 54 | YY-00-0349 | 4 | 26 | Breast Adenocarcinoma | F | U | ductal | |
| 84 | 59 | YY-00-0355 | 4 | 27 | Breast Adenocarcinoma | F | U | lobular with signet rings | |
| 89 | 64 | YY-00-0468 | 4 | 28 | Breast Adenocarcinoma | F | 60 | ductal | |
| 94 | 69 | YY-01-0007 | 4 | 29 | Breast Adenocarcinoma | F | 39 | limited | ductal, c-erb-B2 4+ |
| 99 | 74 | YY-01-0013 | 4 | 30 | Breast Adenocarcinoma | F | 52 | ductal, ER, PR and c-erb-B2 negative | |
| 455 | 5 | normal tissue | 5 | 1 | bone marrow | XX-00-33A | |||
| 460 | 10 | normal tissue | 5 | 2 | breast | ||||
| 465 | 15 | normal tissue | 5 | 3 | colon | ||||
| 470 | 20 | normal tissue | 5 | 4 | kidney, medulla | ||||
| 475 | 25 | normal tissue | 5 | 5 | lung | ||||
| 480 | 30 | normal tissue | 5 | 7 | muscle | ||||
| 485 | 35 | normal tissue | 5 | 8 | placenta, membranes | ||||
| 490 | 40 | normal tissue | 5 | 9 | skin | ||||
| 495 | 45 | normal tissue | 5 | 10 | stomach | ||||
| 500 | 50 | normal tissue | 5 | 11 | uterus, myometrium | ||||
| 30 | 5 | YY-00-0059 | 5 | 14 | Breast Adenocarcinoma | F | 69 | limited | ductal |
| 35 | 10 | YY-00-0065 | 5 | 15 | Breast Adenocarcinoma | F | 69 | limited | lobular |
| 40 | 15 | YY-00-0177 | 5 | 16 | Breast Adenocarcinoma | F | 37 | ductal | |
| 45 | 20 | YY-00-0182 | 5 | 17 | Breast Adenocarcinoma | F | 63 | limited | ductal, IPOX ER, PR and c-erb-B2 negative |
| 50 | 25 | YY-00-0189 | 5 | 18 | Breast Adenocarcinoma | F | 70 | ductal | |
| 55 | 30 | YY-00-0197 | 5 | 20 | Breast Adenocarcinoma | F | 48 | lobular | |
| 60 | 35 | YY-00-0209 | 5 | 21 | Breast Adenocarcinoma | F | 35 | ductal, IPOX ER positive, PR negative | |
| 65 | 40 | YY-00-0214 | 5 | 22 | Breast Adenocarcinoma | F | 45 | ductal | |
| 70 | 45 | YY-00-0331 | 5 | 23 | Breast Adenocarcinoma | F | 59 | limited | poorly differentiated, IPOX positive ER, PR, negative c-erb-B2 |
| 75 | 50 | YY-00-0342 | 5 | 24 | Breast Adenocarcinoma | F | U | ductal | |
| 80 | 55 | YY-00-0351 | 5 | 26 | Breast Adenocarcinoma | F | U | ductal | |
| 85 | 60 | YY-00-0356 | 5 | 27 | Breast Adenocarcinoma | F | U | ductal | |
| 90 | 65 | YY-01-0002 | 5 | 28 | Breast Adenocarcinoma | F | 73 | ductal, ER and PR +, c-erb-B2 3+ | |
| 95 | 70 | YY-01-0008 | 5 | 29 | Breast Adenocarcinoma | F | 56 | limited | lobular, ER +, PR -, c-erb_b2 - |
| 100 | 75 | YY-01-0014 | 5 | 30 | Breast Adenocarcinoma | F | 61 | met to LN, ER, PR and c-erbB2 negative | |
| 101 | 1 | YY-00-0027 | 7 | 14 | Colonic Adenocarcinoma | M | 85 | limited | |
| 106 | 6 | YY-00-0032 | 7 | 15 | Colonic Adenocarcinoma | F | 76 | ||
| 111 | 11 | YY-00-0041 | 7 | 16 | Colonic Adenocarcinoma | M | 67 | ||
| 116 | 16 | YY-00-0223 | 7 | 17 | Colonic Adenocarcinoma | M | 37 | ||
| 121 | 21 | YY-00-0228 | 7 | 18 | Colonic Adenocarcinoma | M | 54 | ||
| 126 | 26 | YY-00-0233 | 7 | 20 | Colonic Adenocarcinoma | F | 76 | liver metastasis | |
| 131 | 31 | YY-00-0238 | 7 | 21 | Colonic Adenocarcinoma | M | 72 | ||
| 136 | 36 | YY-00-0243 | 7 | 22 | Colonic Adenocarcinoma | M | 50 | limited | |
| 141 | 41 | YY-00-0248 | 7 | 23 | Colonic Adenocarcinoma | F | 72 | ||
| 146 | 46 | YY-00-0262 | 7 | 24 | Colonic Adenocarcinoma | F | 75 | limited | |
| 151 | 51 | YY-00-0268 | 7 | 26 | Colonic Adenocarcinoma | M | 56 | ||
| 156 | 56 | YY-00-0278 | 7 | 27 | Colonic Adenocarcinoma | M | 58 | ||
| 161 | 61 | YY-00-0479 | 7 | 28 | Colonic Adenocarcinoma | F | 47 | ||
| 166 | 66 | YY-00-0493 | 7 | 29 | Colonic Adenocarcinoma | F | 70 | ||
| 171 | 71 | YY-01-0018 | 7 | 30 | Colonic Adenocarcinoma | M | 70 | ||
| 1 | 1 | YY-00-0540 | 8 | 1 | Brain Tumor | U | U | GBM | |
| 6 | 6 | YY-00-0545 | 8 | 2 | Brain Tumor | U | U | GBM | |
| 11 | 11 | YY-00-0550 | 8 | 3 | Brain Tumor | U | U | GBM | |
| 16 | 16 | YY-00-0555 | 8 | 4 | Brain Tumor | U | U | GBM | |
| 21 | 21 | YY-00-0560 | 8 | 5 | Brain Tumor | U | U | GBM | |
| 301 | 1 | YY-00-0022 | 8 | 7 | Melanoma | F | 22 | IPOX positive for s100, HMB-45 | |
| 306 | 6 | YY-00-0095 | 8 | 8 | Melanoma | F | 73 | IPOX positive for S100, HMB45, vimentin, negative for Cytokeratin (unspecified) & CD45 | |
| 311 | 11 | YY-00-0257 | 8 | 9 | Melanoma | F | 44 | IPOX positive for S100, HMB45 (focal) | |
| 316 | 16 | YY-00-0505 | 8 | 10 | Melanoma | M | 60 | ||
| 321 | 21 | YY-01-0042 | 8 | 11 | Melanoma | M | 59 | limited | extensive necrosis |
| 102 | 2 | YY-00-0028 | 8 | 14 | Colonic Adenocarcinoma | F | 52 | ||
| 107 | 7 | YY-00-0033 | 8 | 15 | Colonic Adenocarcinoma | M | 87 | ||
| 112 | 12 | YY-00-0043 | 8 | 16 | Colonic Adenocarcinoma | M | 64 | limited | |
| 117 | 17 | YY-00-0224 | 8 | 17 | Colonic Adenocarcinoma | F | 61 | ||
| 122 | 22 | YY-00-0229 | 8 | 18 | Colonic Adenocarcinoma | M | 51 | ||
| 127 | 27 | YY-00-0234 | 8 | 20 | Colonic Adenocarcinoma | M | 81 | ||
| 132 | 32 | YY-00-0239 | 8 | 21 | Colonic Adenocarcinoma | F | 61 | ||
| 137 | 37 | YY-00-0244 | 8 | 22 | Colonic Adenocarcinoma | M | 76 | limited | |
| 142 | 42 | YY-00-0249 | 8 | 23 | Colonic Adenocarcinoma | M | 38 | ||
| 147 | 47 | YY-00-0263 | 8 | 24 | Colonic Adenocarcinoma | F | U | limited | |
| 152 | 52 | YY-00-0269 | 8 | 26 | Colonic Adenocarcinoma | U | U | ||
| 157 | 57 | YY-00-0283 | 8 | 27 | Colonic Adenocarcinoma | M | 68 | ||
| 162 | 62 | YY-00-0480 | 8 | 28 | Colonic Adenocarcinoma | F | 52 | ||
| 167 | 67 | YY-00-0495 | 8 | 29 | Colonic Adenocarcinoma | M | 68 | ||
| 172 | 72 | YY-01-0019 | 8 | 30 | Colonic Adenocarcinoma | F | 68 | limited | |
| 2 | 2 | YY-00-0541 | 9 | 1 | Brain Tumor | U | U | GBM | |
| 7 | 7 | YY-00-0546 | 9 | 2 | Brain Tumor | U | U | GBM | |
| 12 | 12 | YY-00-0551 | 9 | 3 | Brain Tumor | U | U | GBM | |
| 17 | 17 | YY-00-0556 | 9 | 4 | Brain Tumor | U | U | GBM | |
| 22 | 22 | YY-00-0561 | 9 | 5 | Brain Tumor | U | U | GBM | |
| 302 | 2 | YY-00-0023 | 9 | 7 | Melanoma | F | 82 | ||
| 307 | 7 | YY-00-0096 | 9 | 8 | Melanoma | U | U | ||
| 312 | 12 | YY-00-0258 | 9 | 9 | Melanoma | M | 43 | ||
| 317 | 17 | YY-00-0506 | 9 | 10 | Melanoma | F | 71 | ||
| 322 | 22 | YY-01-0043 | 9 | 11 | Melanoma | M | 50 | ||
| 103 | 3 | YY-00-0029 | 9 | 14 | Colonic Adenocarcinoma | F | 49 | Tubular Adenoma only | |
| 108 | 8 | YY-00-0034 | 9 | 15 | Colonic Adenocarcinoma | F | 67 | ||
| 113 | 13 | YY-00-0220 | 9 | 16 | Colonic Adenocarcinoma | U | U | Tubular Adenoma only | |
| 118 | 18 | YY-00-0225 | 9 | 17 | Colonic Adenocarcinoma | F | 77 | ||
| 123 | 23 | YY-00-0230 | 9 | 18 | Colonic Adenocarcinoma | M | 90 | ||
| 128 | 28 | YY-00-0235 | 9 | 20 | Colonic Adenocarcinoma | M | 73 | ||
| 133 | 33 | YY-00-0240 | 9 | 21 | Colonic Adenocarcinoma | F | 58 | ||
| 138 | 38 | YY-00-0245 | 9 | 22 | Colonic Adenocarcinoma | F | 83 | ||
| 143 | 43 | YY-00-0251 | 9 | 23 | Colonic Adenocarcinoma | F | 71 | ||
| 148 | 48 | YY-00-0265 | 9 | 24 | Colonic Adenocarcinoma | U | U | limited | |
| 153 | 53 | YY-00-0273 | 9 | 26 | Colonic Adenocarcinoma | M | 64 | ||
| 158 | 58 | YY-00-0474 | 9 | 27 | Colonic Adenocarcinoma | F | 74 | ||
| 163 | 63 | YY-00-0484 | 9 | 28 | Colonic Adenocarcinoma | U | U | ||
| 168 | 68 | YY-00-0497 | 9 | 29 | Colonic Adenocarcinoma | M | 49 | ||
| 173 | 73 | YY-01-0020 | 9 | 30 | Colonic Adenocarcinoma | F | 73 | ||
| 3 | 3 | YY-00-0542 | 10 | 1 | Brain Tumor | U | U | GBM | |
| 8 | 8 | YY-00-0547 | 10 | 2 | Brain Tumor | U | U | GBM | |
| 13 | 13 | YY-00-0552 | 10 | 3 | Brain Tumor | U | U | GBM | |
| 18 | 18 | YY-00-0557 | 10 | 4 | Brain Tumor | U | U | GBM | |
| 23 | 23 | YY-00-0562 | 10 | 5 | Brain Tumor | U | U | GBM | |
| 303 | 3 | YY-00-0025 | 10 | 7 | Melanoma | M | 41 | IPOX positive S100, melin (sp?) | |
| 308 | 8 | YY-00-0100 | 10 | 8 | Melanoma | F | 78 | IPOX positive for HMB45, negative for S100 | |
| 313 | 13 | YY-00-0499 | 10 | 9 | Melanoma | M | 61 | IPOX positive S100, negative HMB45 | |
| 318 | 18 | YY-00-0507 | 10 | 10 | Melanoma | F | 51 | ||
| 323 | 23 | YY-01-0101 | 10 | 11 | Melanoma | U | U | ||
| 104 | 4 | YY-00-0030 | 10 | 14 | Colonic Adenocarcinoma | F | 67 | limited | |
| 109 | 9 | YY-00-0035 | 10 | 15 | Colonic Adenocarcinoma | F | 86 | limited | |
| 114 | 14 | YY-00-0221 | 10 | 16 | Colonic Adenocarcinoma | U | U | ||
| 119 | 19 | YY-00-0226 | 10 | 17 | Colonic Adenocarcinoma | F | 86 | ||
| 124 | 24 | YY-00-0231 | 10 | 18 | Colonic Adenocarcinoma | M | 72 | ||
| 129 | 29 | YY-00-0236 | 10 | 20 | Colonic Adenocarcinoma | F | 88 | ||
| 134 | 34 | YY-00-0241 | 10 | 21 | Colonic Adenocarcinoma | F | 55 | ||
| 139 | 39 | YY-00-0246 | 10 | 22 | Colonic Adenocarcinoma | M | 52 | ||
| 144 | 44 | YY-00-0252 | 10 | 23 | Colonic Adenocarcinoma | F | 69 | ||
| 149 | 49 | YY-00-0266 | 10 | 24 | Colonic Adenocarcinoma | F | 44 | ||
| 154 | 54 | YY-00-0276 | 10 | 26 | Colonic Adenocarcinoma | M | 57 | ||
| 159 | 59 | YY-00-0475 | 10 | 27 | Colonic Adenocarcinoma | M | 79 | ||
| 164 | 64 | YY-00-0490 | 10 | 28 | Colonic Adenocarcinoma | F | 68 | ||
| 169 | 69 | YY-01-0016 | 10 | 29 | Colonic Adenocarcinoma | M | 61 | ||
| 174 | 74 | YY-01-0021 | 10 | 30 | Colonic Adenocarcinoma | F | 54 | ||
| 4 | 4 | YY-00-0543 | 11 | 1 | Brain Tumor | U | U | GBM | |
| 9 | 9 | YY-00-0548 | 11 | 2 | Brain Tumor | U | U | GBM | |
| 14 | 14 | YY-00-0553 | 11 | 3 | Brain Tumor | U | U | limited | GBM |
| 19 | 19 | YY-00-0558 | 11 | 4 | Brain Tumor | U | U | GBM | |
| 24 | 24 | YY-00-0563 | 11 | 5 | Brain Tumor | U | U | GBM | |
| 304 | 4 | YY-00-0026 | 11 | 7 | Melanoma | F | 79 | IPOX positive for S100, HMB-45, negative AE1/3, CAM5.2 | |
| 309 | 9 | YY-00-0101 | 11 | 8 | Melanoma | M | 83 | IPOX positive for S100, HMB45, negative for cytokeratin (unspecified), CD3, CD20, CD30 | |
| 314 | 14 | YY-00-0502 | 11 | 9 | Melanoma | F | 73 | ||
| 319 | 19 | YY-00-0508 | 11 | 10 | Melanoma | M | 78 | ||
| 324 | 24 | YY-01-0102 | 11 | 11 | Melanoma | U | U | ||
| 105 | 5 | YY-00-0031 | 11 | 14 | Colonic Adenocarcinoma | F | 90 | ||
| 110 | 10 | YY-00-0036 | 11 | 15 | Colonic Adenocarcinoma | F | 77 | limited | |
| 115 | 15 | YY-00-0222 | 11 | 16 | Colonic Adenocarcinoma | M | 39 | ||
| 120 | 20 | YY-00-0227 | 11 | 17 | Colonic Adenocarcinoma | F | 41 | ||
| 125 | 25 | YY-00-0232 | 11 | 18 | Colonic Adenocarcinoma | F | 45 | ||
| 130 | 30 | YY-00-0237 | 11 | 20 | Colonic Adenocarcinoma | M | 71 | ||
| 135 | 35 | YY-00-0242 | 11 | 21 | Colonic Adenocarcinoma | F | 78 | ||
| 140 | 40 | YY-00-0247 | 11 | 22 | Colonic Adenocarcinoma | F | 76 | ||
| 145 | 45 | YY-00-0261 | 11 | 23 | Colonic Adenocarcinoma | M | U | ||
| 150 | 50 | YY-00-0267 | 11 | 24 | Colonic Adenocarcinoma | F | 47 | limited | |
| 155 | 55 | YY-00-0277 | 11 | 26 | Colonic Adenocarcinoma | F | 51 | ||
| 160 | 60 | YY-00-0478 | 11 | 27 | Colonic Adenocarcinoma | M | 64 | ||
| 165 | 65 | YY-00-0492 | 11 | 28 | Colonic Adenocarcinoma | M | 36 | ||
| 170 | 70 | YY-01-0017 | 11 | 29 | Colonic Adenocarcinoma | M | 53 | ||
| 175 | 75 | YY-01-0022 | 11 | 30 | Colonic Adenocarcinoma | F | 78 | mucinous | |
| 5 | 5 | YY-00-0544 | 12 | 1 | Brain Tumor | U | U | GBM | |
| 10 | 10 | YY-00-0549 | 12 | 2 | Brain Tumor | U | U | GBM | |
| 15 | 15 | YY-00-0554 | 12 | 3 | Brain Tumor | U | U | GBM | |
| 20 | 20 | YY-00-0559 | 12 | 4 | Brain Tumor | U | U | GBM | |
| 25 | 25 | YY-00-0564 | 12 | 5 | Brain Tumor | U | U | GBM | |
| 305 | 5 | YY-00-0094 | 12 | 7 | Melanoma | M | 50 | ||
| 310 | 10 | YY-00-0254 | 12 | 8 | Melanoma | M | 50 | ||
| 315 | 15 | YY-00-0503 | 12 | 9 | Melanoma | M | 49 | ||
| 320 | 20 | YY-01-0041 | 12 | 10 | Melanoma | M | 35 | ||
| 325 | 25 | YY-01-0103 | 12 | 11 | Melanoma | U | U | Pos HMB45, S100, Vimentin; Neg LCA, keratin | |
| 176 | 1 | YY-00-0070 | 13 | 14 | Lung Cancer | M | 61 | limited | |
| 181 | 6 | YY-00-0077 | 13 | 15 | Lung Cancer | M | 78 | ||
| 186 | 11 | YY-00-0086 | 13 | 16 | Lung Cancer | U | U | ||
| 191 | 16 | YY-00-0140 | 13 | 17 | Lung Cancer | F | 73 | ||
| 196 | 21 | YY-00-0145 | 13 | 18 | Lung Cancer | F | 54 | limited | |
| 201 | 26 | YY-00-0152 | 13 | 20 | Lung Cancer | F | 67 | ||
| 206 | 31 | YY-00-0158 | 13 | 21 | Lung Cancer | F | 76 | ||
| 211 | 36 | YY-00-0163 | 13 | 22 | Lung Cancer | M | 75 | ||
| 216 | 41 | YY-00-0169 | 13 | 23 | Lung Cancer | M | 66 | limited | |
| 221 | 46 | YY-00-0190 | 13 | 24 | Lung Cancer | F | 38 | ||
| 226 | 51 | YY-00-0312 | 13 | 26 | Lung Cancer | F | 66 | ||
| 231 | 56 | YY-00-0319 | 13 | 27 | Lung Cancer | M | 61 | ||
| 236 | 61 | YY-00-0528 | 13 | 28 | Lung Cancer | M | 40 | ||
| 241 | 66 | YY-00-0534 | 13 | 29 | Lung Cancer | M | 75 | ||
| 246 | 71 | YY-01-0027 | 13 | 30 | Lung Cancer | M | 60 | adeno, with papillary features, thyroglobulin negative | |
| 251 | 1 | YY-00-0011 | 14 | 1 | Lymphoma | M | 14 | IPOX: L-26 positive | |
| 256 | 6 | YY-00-0016 | 14 | 2 | Lymphoma | F | 69 | Hodgkins Lyphoma IPOX: R-S cells positive Ki-1, Leu-M1 | |
| 261 | 11 | YY-00-0045 | 14 | 3 | Lymphoma | M | 46 | IPOX positive for CD20, CD45R, negative CDw75, CD3, CD43, CD45RO | |
| 266 | 16 | YY-00-0051 | 14 | 4 | Lymphoma | F | 29 | IPOX positive for CD20, CD10, CD5 (weak), negative for CD43, CD3, cyclin D1 | |
| 271 | 21 | YY-00-0128 | 14 | 5 | Lymphoma | F | 34 | Hodgkins Lymphoma, R-S cells IPOX positive for CD15, CD30, CD20(focal) | |
| 276 | 26 | YY-00-0135 | 14 | 7 | Lymphoma | F | 39 | IPOX positive for CD20, CD30, negative for CD3, CD15, EMA | |
| 281 | 31 | YY-00-0298 | 14 | 8 | Lymphoma | F | U | IPOX positive for CD20 | |
| 286 | 36 | YY-00-0303 | 14 | 9 | Lymphoma | F | 59 | ||
| 291 | 41 | YY-01-0038 | 14 | 10 | Lymphoma | F | 70 | B-cell, CD20, CD79a, CD30 pos, S-100, LeuM1, CD15 neg | |
| 296 | 46 | YY-01-0057 | 14 | 11 | Lymphoma | M | 69 | Large T cell, pos CD45RO, CD30, CD3, neg for CD20, EMA , CD45R | |
| 177 | 2 | YY-00-0071 | 14 | 14 | Lung Cancer | F | 74 | ||
| 182 | 7 | YY-00-0078 | 14 | 15 | Lung Cancer | F | 84 | ||
| 187 | 12 | YY-00-0089 | 14 | 16 | Lung Cancer | U | U | ||
| 192 | 17 | YY-00-0141 | 14 | 17 | Lung Cancer | M | 51 | ||
| 197 | 22 | YY-00-0146 | 14 | 18 | Lung Cancer | F | 80 | ||
| 202 | 27 | YY-00-0153 | 14 | 20 | Lung Cancer | M | 51 | ||
| 207 | 32 | YY-00-0159 | 14 | 21 | Lung Cancer | M | 62 | ||
| 212 | 37 | YY-00-0165 | 14 | 22 | Lung Cancer | M | 73 | ||
| 217 | 42 | YY-00-0170 | 14 | 23 | Lung Cancer | F | 59 | ||
| 222 | 47 | YY-00-0305 | 14 | 24 | Lung Cancer | F | 73 | limited | |
| 227 | 52 | YY-00-0314 | 14 | 26 | Lung Cancer | U | U | ||
| 232 | 57 | YY-00-0320 | 14 | 27 | Lung Cancer | M | 71 | ||
| 237 | 62 | YY-00-0529 | 14 | 28 | Lung Cancer | F | 37 | ||
| 242 | 67 | YY-00-0536 | 14 | 29 | Lung Cancer | M | 69 | ||
| 247 | 72 | YY-01-0028 | 14 | 30 | Lung Cancer | M | 66 | squamous | |
| 252 | 2 | YY-00-0012 | 15 | 1 | Lymphoma | M | 59 | IPOX: positive for CD19, CD20, CD22, CD10, lambda | |
| 257 | 7 | YY-00-0017 | 15 | 2 | Lymphoma | M | 89 | IPOX: positive for T-marker (unspecfied), CD30 | |
| 262 | 12 | YY-00-0046 | 15 | 3 | Lymphoma | M | 40 | PTLD, EBV negatve, clonal by PCR, IPOX CD20 positive | |
| 267 | 17 | YY-00-0124 | 15 | 4 | Lymphoma | M | U | IPOX positive for CD20 | |
| 272 | 22 | YY-00-0129 | 15 | 5 | Lymphoma | M | 75 | IPOX positive for CD20, CD23, CD21, negative CD3, CD43 | |
| 277 | 27 | YY-00-0137 | 15 | 7 | Lymphoma | M | 63 | Flow positive for CD19, CD20/CD5 (coexpression) and CD23 | |
| 282 | 32 | YY-00-0299 | 15 | 8 | Lymphoma | M | 74 | ||
| 287 | 37 | YY-00-0304 | 15 | 9 | Lymphoma | M | 37 | Hodgkins Lymphoma IPOX positive L-26, EMA, negative for LeuM1, CD30 | |
| 292 | 42 | YY-01-0039 | 15 | 10 | Lymphoma | M | 39 | spleen, flow CD2, CD3, CD56, CD16 pos, CD7 dim | |
| 297 | 47 | YY-01-0058 | 15 | 11 | Lymphoma | U | U | HD, NS, RS cells CD30 pos | |
| 178 | 3 | YY-00-0072 | 15 | 14 | Lung Cancer | M | 63 | ||
| 183 | 8 | YY-00-0080 | 15 | 15 | Lung Cancer | M | 67 | ||
| 188 | 13 | YY-00-0092 | 15 | 16 | Lung Cancer | F | 50 | ||
| 193 | 18 | YY-00-0142 | 15 | 17 | Lung Cancer | F | 73 | ||
| 198 | 23 | YY-00-0149 | 15 | 18 | Lung Cancer | M | 61 | ||
| 203 | 28 | YY-00-0154 | 15 | 20 | Lung Cancer | M | 68 | limited | |
| 208 | 33 | YY-00-0160 | 15 | 21 | Lung Cancer | F | 71 | ||
| 213 | 38 | YY-00-0166 | 15 | 22 | Lung Cancer | M | 74 | limited | |
| 218 | 43 | YY-00-0171 | 15 | 23 | Lung Cancer | M | U | limited | |
| 223 | 48 | YY-00-0306 | 15 | 24 | Lung Cancer | M | 70 | limited | |
| 228 | 53 | YY-00-0315 | 15 | 26 | Lung Cancer | M | 54 | ||
| 233 | 58 | YY-00-0322 | 15 | 27 | Lung Cancer | F | 80 | ||
| 238 | 63 | YY-00-0530 | 15 | 28 | Lung Cancer | M | 56 | ||
| 243 | 68 | YY-00-0537 | 15 | 29 | Lung Cancer | F | 73 | ||
| 248 | 73 | YY-01-0029 | 15 | 30 | Lung Cancer | F | 58 | squamous | |
| 253 | 3 | YY-00-0013 | 16 | 1 | Lymphoma | F | 79 | IPOX: positive for CD19, CD20, lambda | |
| 258 | 8 | YY-00-0018 | 16 | 2 | Lymphoma | M | 89 | IPOX: positive CD4, CD13, CD30, EMA, vimentin, negative for L-26, CD43 | |
| 263 | 13 | YY-00-0047 | 16 | 3 | Lymphoma | M | 71 | ||
| 268 | 18 | YY-00-0125 | 16 | 4 | Lymphoma | F | 79 | Spleen, Flow Kappa restricted, B-cell lineage | |
| 273 | 23 | YY-00-0131 | 16 | 5 | Lymphoma | M | 34 | PTLD, s/p transplant (not specified) | |
| 278 | 28 | YY-00-0294 | 16 | 7 | Lymphoma | M | 54 | ||
| 283 | 33 | YY-00-0300 | 16 | 8 | Lymphoma | M | 51 | ||
| 288 | 38 | YY-00-0509 | 16 | 9 | Lymphoma | M | 54 | ||
| 293 | 43 | YY-01-0040 | 16 | 10 | Lymphoma | F | 68 | spleen, flow CD19, CD20, Kappa, surface IgM pos, CD5 dim | |
| 298 | 48 | YY-01-0060 | 16 | 11 | Lymphoma | M | 6 | flow CD45, CD19, CD20, CD22, Kappa | |
| 179 | 4 | YY-00-0073 | 16 | 14 | Lung Cancer | F | 48 | ||
| 184 | 9 | YY-00-0081 | 16 | 15 | Lung Cancer | M | 75 | ||
| 189 | 14 | YY-00-0093 | 16 | 16 | Lung Cancer | M | 71 | ||
| 194 | 19 | YY-00-0143 | 16 | 17 | Lung Cancer | M | 78 | ||
| 199 | 24 | YY-00-0150 | 16 | 18 | Lung Cancer | U | U | ||
| 204 | 29 | YY-00-0155 | 16 | 20 | Lung Cancer | M | 50 | ||
| 209 | 34 | YY-00-0161 | 16 | 21 | Lung Cancer | M | 65 | ||
| 214 | 39 | YY-00-0167 | 16 | 22 | Lung Cancer | M | 70 | limited | |
| 219 | 44 | YY-00-0172 | 16 | 23 | Lung Cancer | M | 62 | ||
| 224 | 49 | YY-00-0308 | 16 | 24 | Lung Cancer | M | 66 | limited | |
| 229 | 54 | YY-00-0316 | 16 | 26 | Lung Cancer | F | 72 | ||
| 234 | 59 | YY-00-0328 | 16 | 27 | Lung Cancer | M | 73 | ||
| 239 | 64 | YY-00-0531 | 16 | 28 | Lung Cancer | M | 62 | ||
| 244 | 69 | YY-01-0025 | 16 | 29 | Lung Cancer | M | 70 | squamous | |
| 249 | 74 | YY-01-0030 | 16 | 30 | Lung Cancer | M | 71 | squamous | |
| 254 | 4 | YY-00-0014 | 17 | 1 | Lymphoma | U | 16 | IPOX: positive for CD30, CD15 (focal), negative for CD20, EMA, UCHL1 | |
| 259 | 9 | YY-00-0020 | 17 | 2 | Lymphoma | M | 24 | ||
| 264 | 14 | YY-00-0049 | 17 | 3 | Lymphoma | M | 69 | IPOX positive for CD30, CD45RO, CD3 9weak), negative for CD20, CD45R and EMA | |
| 269 | 19 | YY-00-0126 | 17 | 4 | Lymphoma | F | 74 | Flow, positive for CD10, CD19, CD20, lambda | |
| 274 | 24 | YY-00-0132 | 17 | 5 | Lymphoma | F | 37 | IPOX positive for CD20, CD79a, CD45, negative for S100, cytokertatin, CD15, CD3 | |
| 279 | 29 | YY-00-0295 | 17 | 7 | Lymphoma | F | 34 | spleen, IPOX Positive for CD20, CD19, negative for CD5, CD23, CD10 | |
| 284 | 34 | YY-00-0301 | 17 | 8 | Lymphoma | M | 53 | ||
| 289 | 39 | YY-00-0510 | 17 | 9 | Lymphoma | M | 11 | Hodgkins Lymphoma | |
| 294 | 44 | YY-01-0055 | 17 | 10 | Lymphoma | M | 56 | spleen, B- cell,CD20 positive | |
| 299 | 49 | YY-01-0105 | 17 | 11 | Lymphoma | M | U | ||
| 180 | 5 | YY-00-0075 | 17 | 14 | Lung Cancer | F | 75 | ||
| 185 | 10 | YY-00-0082 | 17 | 15 | Lung Cancer | F | 64 | ||
| 190 | 15 | YY-00-0139 | 17 | 16 | Lung Cancer | M | 75 | ||
| 195 | 20 | YY-00-0144 | 17 | 17 | Lung Cancer | F | 71 | ||
| 200 | 25 | YY-00-0151 | 17 | 18 | Lung Cancer | F | 40 | ||
| 205 | 30 | YY-00-0156 | 17 | 20 | Lung Cancer | M | 64 | ||
| 210 | 35 | YY-00-0162 | 17 | 21 | Lung Cancer | M | 47 | ||
| 215 | 40 | YY-00-0168 | 17 | 22 | Lung Cancer | M | 54 | ||
| 220 | 45 | YY-00-0173 | 17 | 23 | Lung Cancer | M | 46 | ||
| 225 | 50 | YY-00-0309 | 17 | 24 | Lung Cancer | F | 56 | ||
| 230 | 55 | YY-00-0318 | 17 | 26 | Lung Cancer | M | 54 | ||
| 235 | 60 | YY-00-0527 | 17 | 27 | Lung Cancer | M | 77 | ||
| 240 | 65 | YY-00-0532 | 17 | 28 | Lung Cancer | F | 76 | ||
| 245 | 70 | YY-01-0026 | 17 | 29 | Lung Cancer | M | 68 | squamous | |
| 250 | 75 | YY-01-0032 | 17 | 30 | Lung Cancer | F | 67 | squamous | |
| 255 | 5 | YY-00-0015 | 18 | 1 | Lymphoma | M | 49 | ||
| 260 | 10 | YY-00-0021 | 18 | 2 | Lymphoma | M | 99 | B-cell phenotype by flow | |
| 265 | 15 | YY-00-0050 | 18 | 3 | Lymphoma | M | 67 | IPOX positive for CD3, CD30, CD43, CD45RO, negative for CD20, CD45R, CD75 & Alk | |
| 270 | 20 | YY-00-0127 | 18 | 4 | Lymphoma | F | 81 | IPOX positive CD20, CD10, negative CD3, cyclin D1 | |
| 275 | 25 | YY-00-0134 | 18 | 5 | Lymphoma | M | 58 | IPOX positive for CD19, CD20, FMC7, lambda, negative for CD5, CD23 | |
| 280 | 30 | YY-00-0297 | 18 | 7 | Lymphoma | M | 69 | spleen, flow negative for CD5 and CD10 | |
| 285 | 35 | YY-00-0302 | 18 | 8 | Lymphoma | F | 20 | Hodgkins Lymphoma, IPOX positive CD30, CD15, CD20 , status post treatment | |
| 290 | 40 | YY-00-0513 | 18 | 9 | Lymphoma | M | 59 | IPOX positive CD5, CD20, CD23 | |
| 295 | 45 | YY-01-0056 | 18 | 10 | Lymphoma | F | 21 | HD, NS | |
| 300 | 50 | YY-01-0123 | 18 | 11 | Lymphoma | U | U | SLL/CLL | |
| 376 | 1 | YY-00-0362 | 19 | 14 | Prostatic Adenocarcinoma | M | U | ||
| 381 | 6 | YY-00-0368 | 19 | 15 | Prostatic Adenocarcinoma | M | U | limited | |
| 386 | 11 | YY-00-0373 | 19 | 16 | Prostatic Adenocarcinoma | M | U | ||
| 391 | 16 | YY-00-0382 | 19 | 17 | Prostatic Adenocarcinoma | M | U | ||
| 396 | 21 | YY-00-0390 | 19 | 18 | Prostatic Adenocarcinoma | M | U | ||
| 401 | 26 | YY-00-0397 | 19 | 20 | Prostatic Adenocarcinoma | M | U | ||
| 406 | 31 | YY-00-0408 | 19 | 21 | Prostatic Adenocarcinoma | M | U | ||
| 411 | 36 | YY-00-0413 | 19 | 22 | Prostatic Adenocarcinoma | M | U | limited | |
| 416 | 41 | YY-00-0419 | 19 | 23 | Prostatic Adenocarcinoma | M | U | limited | |
| 421 | 46 | YY-00-0425 | 19 | 24 | Prostatic Adenocarcinoma | M | U | ||
| 426 | 51 | YY-00-0433 | 19 | 26 | Prostatic Adenocarcinoma | M | U | ||
| 431 | 56 | YY-00-0438 | 19 | 27 | Prostatic Adenocarcinoma | M | U | ||
| 436 | 61 | YY-00-0444 | 19 | 28 | Prostatic Adenocarcinoma | M | U | ||
| 441 | 66 | YY-00-0450 | 19 | 29 | Prostatic Adenocarcinoma | M | U | ||
| 446 | 71 | YY-00-0455 | 19 | 30 | Prostatic Adenocarcinoma | M | U | ||
| 326 | 1 | YY-00-0001 | 20 | 1 | Ovarian Adenocarcinoma | F | U | mucinous | |
| 331 | 6 | YY-00-0009 | 20 | 2 | Ovarian Adenocarcinoma | F | 59 | serous papillary | |
| 336 | 11 | YY-00-0109 | 20 | 3 | Ovarian Adenocarcinoma | F | 50 | clear cell Ca | |
| 341 | 16 | YY-00-0119 | 20 | 4 | Ovarian Adenocarcinoma | F | 47 | serous papillary | |
| 346 | 21 | YY-00-0285 | 20 | 5 | Ovarian Adenocarcinoma | F | U | serous papillary | |
| 351 | 26 | YY-00-0292 | 20 | 7 | Ovarian Adenocarcinoma | F | U | serous papillary | |
| 356 | 31 | YY-00-0519 | 20 | 8 | Ovarian Adenocarcinoma | F | 72 | serous papillary | |
| 361 | 36 | YY-01-0036 | 20 | 9 | Ovarian Adenocarcinoma | F | 78 | endometroid | |
| 366 | 41 | YY-01-0062 | 20 | 10 | Ovarian Adenocarcinoma | F | 59 | endometroid | |
| 371 | 46 | YY-01-0111 | 20 | 11 | Ovarian Adenocarcinoma | F | U | papillary serous adenoca | |
| 377 | 2 | YY-00-0363 | 20 | 14 | Prostatic Adenocarcinoma | M | U | ||
| 382 | 7 | YY-00-0369 | 20 | 15 | Prostatic Adenocarcinoma | M | U | ||
| 387 | 12 | YY-00-0377 | 20 | 16 | Prostatic Adenocarcinoma | M | U | ||
| 392 | 17 | YY-00-0384 | 20 | 17 | Prostatic Adenocarcinoma | M | U | ||
| 397 | 22 | YY-00-0391 | 20 | 18 | Prostatic Adenocarcinoma | M | U | limited | |
| 402 | 27 | YY-00-0400 | 20 | 20 | Prostatic Adenocarcinoma | M | U | ||
| 407 | 32 | YY-00-0409 | 20 | 21 | Prostatic Adenocarcinoma | M | U | ||
| 412 | 37 | YY-00-0414 | 20 | 22 | Prostatic Adenocarcinoma | M | U | ||
| 417 | 42 | YY-00-0420 | 20 | 23 | Prostatic Adenocarcinoma | M | U | limited | |
| 422 | 47 | YY-00-0427 | 20 | 24 | Prostatic Adenocarcinoma | M | U | ||
| 427 | 52 | YY-00-0434 | 20 | 26 | Prostatic Adenocarcinoma | M | U | ||
| 432 | 57 | YY-00-0439 | 20 | 27 | Prostatic Adenocarcinoma | M | U | ||
| 437 | 62 | YY-00-0445 | 20 | 28 | Prostatic Adenocarcinoma | M | U | ||
| 442 | 67 | YY-00-0451 | 20 | 29 | Prostatic Adenocarcinoma | M | U | ||
| 447 | 72 | YY-00-0456 | 20 | 30 | Prostatic Adenocarcinoma | M | U | ||
| 327 | 2 | YY-00-0002 | 21 | 1 | Ovarian Adenocarcinoma | F | 54 | serous papillary | |
| 332 | 7 | YY-00-0010 | 21 | 2 | Ovarian Adenocarcinoma | F | 79 | limited | serous papillary |
| 337 | 12 | YY-00-0110 | 21 | 3 | Ovarian Adenocarcinoma | F | 25 | mucinous cystadenoma, uncertain malignant potential | |
| 342 | 17 | YY-00-0120 | 21 | 4 | Ovarian Adenocarcinoma | F | 23 | mucinous | |
| 347 | 22 | YY-00-0286 | 21 | 5 | Ovarian Adenocarcinoma | F | 62 | serous papillary | |
| 352 | 27 | YY-00-0293 | 21 | 7 | Ovarian Adenocarcinoma | F | 76 | serous papillary | |
| 357 | 32 | YY-00-0521 | 21 | 8 | Ovarian Adenocarcinoma | F | 41 | serous papillary | |
| 362 | 37 | YY-01-0037 | 21 | 9 | Ovarian Adenocarcinoma | F | 47 | papillary serous | |
| 367 | 42 | YY-01-0063 | 21 | 10 | Ovarian Adenocarcinoma | F | 46 | clear cell Ca | |
| 372 | 47 | YY-01-0112 | 21 | 11 | Ovarian Adenocarcinoma | F | U | papillary serous adenoca | |
| 378 | 3 | YY-00-0364 | 21 | 14 | Prostatic Adenocarcinoma | M | U | ||
| 383 | 8 | YY-00-0370 | 21 | 15 | Prostatic Adenocarcinoma | M | U | ||
| 388 | 13 | YY-00-0378 | 21 | 16 | Prostatic Adenocarcinoma | M | U | ||
| 393 | 18 | YY-00-0386 | 21 | 17 | Prostatic Adenocarcinoma | M | U | ||
| 398 | 23 | YY-00-0393 | 21 | 18 | Prostatic Adenocarcinoma | M | U | ||
| 403 | 28 | YY-00-0401 | 21 | 20 | Prostatic Adenocarcinoma | M | U | limited | |
| 408 | 33 | YY-00-0410 | 21 | 21 | Prostatic Adenocarcinoma | M | U | ||
| 413 | 38 | YY-00-0415 | 21 | 22 | Prostatic Adenocarcinoma | M | U | limited | |
| 418 | 43 | YY-00-0422 | 21 | 23 | Prostatic Adenocarcinoma | M | U | ||
| 423 | 48 | YY-00-0428 | 21 | 24 | Prostatic Adenocarcinoma | M | U | ||
| 428 | 53 | YY-00-0435 | 21 | 26 | Prostatic Adenocarcinoma | M | U | ||
| 433 | 58 | YY-00-0440 | 21 | 27 | Prostatic Adenocarcinoma | M | U | ||
| 438 | 63 | YY-00-0447 | 21 | 28 | Prostatic Adenocarcinoma | M | U | ||
| 443 | 68 | YY-00-0452 | 21 | 29 | Prostatic Adenocarcinoma | M | U | ||
| 448 | 73 | YY-00-0457 | 21 | 30 | Prostatic Adenocarcinoma | M | U | ||
| 328 | 3 | YY-00-0005 | 22 | 1 | Ovarian Adenocarcinoma | F | 43 | serous papillary | |
| 333 | 8 | YY-00-0105 | 22 | 2 | Ovarian Adenocarcinoma | F | 69 | serous papillary | |
| 338 | 13 | YY-00-0114 | 22 | 3 | Ovarian Adenocarcinoma | F | 49 | endometroid | |
| 343 | 18 | YY-00-0121 | 22 | 4 | Ovarian Adenocarcinoma | F | 69 | serous papillary | |
| 348 | 23 | YY-00-0288 | 22 | 5 | Ovarian Adenocarcinoma | F | U | serous papillary | |
| 353 | 28 | YY-00-0515 | 22 | 7 | Ovarian Adenocarcinoma | F | 62 | serous papillary | |
| 358 | 33 | YY-00-0523 | 22 | 8 | Ovarian Adenocarcinoma | F | 67 | endometroid | |
| 363 | 38 | YY-01-0051 | 22 | 9 | Ovarian Adenocarcinoma | F | 73 | papillary serous | |
| 368 | 43 | YY-01-0100 | 22 | 10 | Ovarian Adenocarcinoma | F | 67 | papillary serous | |
| 373 | 48 | blank | 22 | 11 | Ovarian Adenocarcinoma | BLANK | |||
| 379 | 4 | YY-00-0366 | 22 | 14 | Prostatic Adenocarcinoma | M | U | limited | |
| 384 | 9 | YY-00-0371 | 22 | 15 | Prostatic Adenocarcinoma | M | U | ||
| 389 | 14 | YY-00-0379 | 22 | 16 | Prostatic Adenocarcinoma | M | U | ||
| 394 | 19 | YY-00-0387 | 22 | 17 | Prostatic Adenocarcinoma | M | U | ||
| 399 | 24 | YY-00-0394 | 22 | 18 | Prostatic Adenocarcinoma | M | U | ||
| 404 | 29 | YY-00-0403 | 22 | 20 | Prostatic Adenocarcinoma | M | U | ||
| 409 | 34 | YY-00-0411 | 22 | 21 | Prostatic Adenocarcinoma | M | U | limited | |
| 414 | 39 | YY-00-0416 | 22 | 22 | Prostatic Adenocarcinoma | M | U | ||
| 419 | 44 | YY-00-0423 | 22 | 23 | Prostatic Adenocarcinoma | M | U | limited | |
| 424 | 49 | YY-00-0430 | 22 | 24 | Prostatic Adenocarcinoma | M | U | ||
| 429 | 54 | YY-00-0436 | 22 | 26 | Prostatic Adenocarcinoma | M | U | ||
| 434 | 59 | YY-00-0441 | 22 | 27 | Prostatic Adenocarcinoma | M | U | ||
| 439 | 64 | YY-00-0448 | 22 | 28 | Prostatic Adenocarcinoma | M | U | ||
| 444 | 69 | YY-00-0453 | 22 | 29 | Prostatic Adenocarcinoma | M | U | ||
| 449 | 74 | YY-00-0458 | 22 | 30 | Prostatic Adenocarcinoma | M | U | ||
| 329 | 4 | YY-00-0007 | 23 | 1 | Ovarian Adenocarcinoma | F | 74 | serous papillary | |
| 334 | 9 | YY-00-0106 | 23 | 2 | Ovarian Adenocarcinoma | F | 56 | serous papillary | |
| 339 | 14 | YY-00-0117 | 23 | 3 | Ovarian Adenocarcinoma | F | 47 | endometroid | |
| 344 | 19 | YY-00-0123 | 23 | 4 | Ovarian Adenocarcinoma | F | 74 | serous papillary | |
| 349 | 24 | YY-00-0289 | 23 | 5 | Ovarian Adenocarcinoma | F | U | serous papillary | |
| 354 | 29 | YY-00-0517 | 23 | 7 | Ovarian Adenocarcinoma | F | 60 | serous papillary | |
| 359 | 34 | YY-00-0524 | 23 | 8 | Ovarian Adenocarcinoma | F | 60 | serous papillary | |
| 364 | 39 | YY-01-0052 | 23 | 9 | Ovarian Adenocarcinoma | F | 57 | limited | papillary serous, possible fallopian origin |
| 369 | 44 | YY-01-0109 | 23 | 10 | Ovarian Adenocarcinoma | F | U | clear cell Ca | |
| 374 | 49 | blank | 23 | 11 | Ovarian Adenocarcinoma | BLANK | |||
| 380 | 5 | YY-00-0367 | 23 | 14 | Prostatic Adenocarcinoma | M | U | ||
| 385 | 10 | YY-00-0372 | 23 | 15 | Prostatic Adenocarcinoma | M | U | ||
| 390 | 15 | YY-00-0381 | 23 | 16 | Prostatic Adenocarcinoma | M | U | ||
| 395 | 20 | YY-00-0389 | 23 | 17 | Prostatic Adenocarcinoma | M | U | ||
| 400 | 25 | YY-00-0395 | 23 | 18 | Prostatic Adenocarcinoma | M | U | limited | |
| 405 | 30 | YY-00-0404 | 23 | 20 | Prostatic Adenocarcinoma | M | U | ||
| 410 | 35 | YY-00-0412 | 23 | 21 | Prostatic Adenocarcinoma | M | U | ||
| 415 | 40 | YY-00-0418 | 23 | 22 | Prostatic Adenocarcinoma | M | U | ||
| 420 | 45 | YY-00-0424 | 23 | 23 | Prostatic Adenocarcinoma | M | U | ||
| 425 | 50 | YY-00-0431 | 23 | 24 | Prostatic Adenocarcinoma | M | U | limited | |
| 430 | 55 | YY-00-0437 | 23 | 26 | Prostatic Adenocarcinoma | M | U | ||
| 435 | 60 | YY-00-0442 | 23 | 27 | Prostatic Adenocarcinoma | M | U | ||
| 440 | 65 | YY-00-0449 | 23 | 28 | Prostatic Adenocarcinoma | M | U | ||
| 445 | 70 | YY-00-0454 | 23 | 29 | Prostatic Adenocarcinoma | M | U | ||
| 450 | 75 | YY-00-0459 | 23 | 30 | Prostatic Adenocarcinoma | M | U | ||
| 330 | 5 | YY-00-0008 | 24 | 1 | Ovarian Adenocarcinoma | F | 69 | serous papillary | |
| 335 | 10 | YY-00-0107 | 24 | 2 | Ovarian Adenocarcinoma | F | 68 | limited | clear cell Ca |
| 340 | 15 | YY-00-0118 | 24 | 3 | Ovarian Adenocarcinoma | F | 74 | serous papillary | |
| 345 | 20 | YY-00-0284 | 24 | 4 | Ovarian Adenocarcinoma | F | 31 | serous papillary | |
| 350 | 25 | YY-00-0290 | 24 | 5 | Ovarian Adenocarcinoma | F | U | clear cell Ca | |
| 355 | 30 | YY-00-0518 | 24 | 7 | Ovarian Adenocarcinoma | F | 52 | serous papillary | |
| 360 | 35 | YY-01-0035 | 24 | 8 | Ovarian Adenocarcinoma | F | 67 | papillary serous | |
| 365 | 40 | YY-01-0053 | 24 | 9 | Ovarian Adenocarcinoma | F | 58 | papillary serous | |
| 370 | 45 | YY-01-0110 | 24 | 10 | Ovarian Adenocarcinoma | F | U | poorly differentiated with clear cell features | |
| 375 | 50 | blank | 24 | 11 | Ovarian Adenocarcinoma | BLANK |
A service of the National Cancer Institute
